- Browse by Author
Browsing by Author "Najmi, Saltanat"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item 417 Design and rationale of a phase 1 study evaluating AMG 256, a novel, targeted, IL-21 receptor agonist and anti-PD-1 antibody, in patients with advanced solid tumors(BMJ, 2020-11) Durm, Gregory; Frentzas, Sophia; Rasmussen, Erik; Najmi, Saltanat; Sadraei, Nooshin; Medicine, School of Medicine